Repression of arterial genes in hemogenic endothelium is sufficient for haematopoietic fate acquisition.

Autor: Lizama CO; Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California 94158, USA., Hawkins JS; Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California 94158, USA., Schmitt CE; Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California 94158, USA., Bos FL; Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California 94158, USA., Zape JP; Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California 94158, USA., Cautivo KM; Department of Nutrition, Diabetes, and Metabolism, School of Medicine, Pontificia Universidad Católica de Chile, Santiago 8331150, Chile., Borges Pinto H; Burke Medical Research Institute, White Plains, New York 10605, USA.; Department of Neuroscience, Brain and Mind Research Institute, Weill Cornell Medical College, New York, New York 10065, USA.; Department of Cell and Developmental Biology, Weill Cornell Medical College, New York, New York 10065, USA., Rhyner AM; Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Texas 77030, USA.; Cardiovascular Research Institute, Baylor College of Medicine, Houston, Texas 77030, USA., Yu H; Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California 94158, USA., Donohoe ME; Burke Medical Research Institute, White Plains, New York 10605, USA.; Department of Neuroscience, Brain and Mind Research Institute, Weill Cornell Medical College, New York, New York 10065, USA.; Department of Cell and Developmental Biology, Weill Cornell Medical College, New York, New York 10065, USA., Wythe JD; Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Texas 77030, USA.; Cardiovascular Research Institute, Baylor College of Medicine, Houston, Texas 77030, USA., Zovein AC; Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California 94158, USA.; Department of Pediatrics, Division of Neonatology, School of Medicine, University of California, San Francisco, San Francisco, California 94143, USA.
Jazyk: angličtina
Zdroj: Nature communications [Nat Commun] 2015 Jul 23; Vol. 6, pp. 7739. Date of Electronic Publication: 2015 Jul 23.
DOI: 10.1038/ncomms8739
Abstrakt: Changes in cell fate and identity are essential for endothelial-to-haematopoietic transition (EHT), an embryonic process that generates the first adult populations of haematopoietic stem cells (HSCs) from hemogenic endothelial cells. Dissecting EHT regulation is a critical step towards the production of in vitro derived HSCs. Yet, we do not know how distinct endothelial and haematopoietic fates are parsed during the transition. Here we show that genes required for arterial identity function later to repress haematopoietic fate. Tissue-specific, temporally controlled, genetic loss of arterial genes (Sox17 and Notch1) during EHT results in increased production of haematopoietic cells due to loss of Sox17-mediated repression of haematopoietic transcription factors (Runx1 and Gata2). However, the increase in EHT can be abrogated by increased Notch signalling. These findings demonstrate that the endothelial haematopoietic fate switch is actively repressed in a population of endothelial cells, and that derepression of these programs augments haematopoietic output.
Databáze: MEDLINE